|
|
|
40
|
0752K
|
HYOSCINE BUTYLBROMIDE 20MG/ML INJ (MON/PHA)
|
HYOSCINE BUTYLBROMIDE
|
HYOSCINE BUTYLBROMIDE
|
10X1ML
|
B
|
16.26
|
1.63
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
120808
|
ANTIMUSCARINICS/ANTISPASMODICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
0752L
|
BUSCOPAN 20MG/ML INJ (SFA/COL) HYOSCINE BUTYL
|
HYOSCINE BUTYLBROMIDE
|
BUSCOPAN
|
10X1ML
|
C
|
20.39
|
2.04
|
INJECTION
|
0
|
AMP
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
120808
|
ANTIMUSCARINICS/ANTISPASMODICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
0752L
|
BUSCOPAN 20MG/ML INJ (SFA/COL) HYOSCINE BUTYL (C)
|
HYOSCINE BUTYLBROMIDE
|
BUSCOPAN
|
10X1ML
|
C
|
26.37
|
2.637
|
INJECTION
|
|
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
1208
|
ANTICHOLINERGIC AGENTS
|
2022-12-10
|
2024-03-31
|
Price Change
|
IV
|
0
|
ANTICHOLINERGIC AGENTS
|
2022-12-09
|
|
|
|
41
|
0752M
|
HYOSCINE BUTYLBROMIDE 20MG/ML INJ (FSB) (B)
|
HYOSCINE BUTYLBROMIDE
|
HYOSCINE BUTYLBROMIDE
|
10X1ML
|
B
|
10.66
|
1.0656
|
AMP
|
20
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
120808
|
ANTIMUSCARINICS/ANTISPASMODICS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
ANTIMUSCARINICS/ANTISPASMODICS
|
|
|
|
|
40
|
07918
|
ADRENALINE 1MG/ML IV/IM INJ (RTM/PHA)
|
ADRENALINE
|
ADRENALINE
|
10X1ML
|
B
|
35.01
|
3.50
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2022-06-01
|
2024-03-31
|
Price Change
|
IV/IM
|
0
|
AUTONOMIC DRUGS
|
2022-05-31
|
|
|
|
40
|
07918A
|
ADRENALINE 1MG/ML IV/IM INJ (RTM/PHA)
|
ADRENALINE
|
ADRENALINE
|
10X1ML
|
B
|
24.14
|
2.41
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2022-04-01
|
2022-05-31
|
|
IV/IM
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
0791AF
|
ADRENALINE 1MG/ML IV/IM INJ (MON/PHA)
|
ADRENALINE
|
ADRENALINE
|
10X1ML
|
B
|
7.07
|
0.71
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
0791X
|
ADRENALINE 1MG/ML IV/IM INJ (LAF/AHI)
|
ADRENALINE
|
ADRENALINE
|
100X1ML
|
B
|
99.38
|
0.99
|
INJECTION
|
0
|
AMP
|
LAF
|
LABORATORIOS ALFA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
Change Local Agent
|
IV/IM
|
0
|
AUTONOMIC DRUGS
|
2022-02-03
|
|
|
|
41
|
0791X
|
ADRENALINE 1MG/ML IV/IM INJ (LAF) (B)
|
ADRENALINE
|
ADRENALINE
|
100X1ML
|
B
|
114.17
|
1.1417
|
AMP
|
60
|
BOX
|
LAF
|
LABORATORIOS ALFA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
ALPHA & BETA ADRENERGIC AGONIST
|
|
|
|
|
41
|
0791Y
|
ADRINOR 1MG/ML IV/IM INJ (INC) ADRENALINE (B)
|
ADRENALINE
|
ADRINOR
|
5X1ML
|
B
|
9.05
|
1.8104
|
AMP
|
60
|
BOX
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV/IM/SC
|
0
|
ALPHA & BETA ADRENERGIC AGONIST
|
|
|
|
|
41
|
08011
|
DOPAMINE 40MG/ML INJ (RTM) (B)
|
DOPAMINE
|
DOPAMINE
|
10X5ML
|
B
|
114.5
|
11.4496
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
40
|
0801P
|
DOPAMINE 40MG/ML INJ (SLS/AHI)
|
DOPAMINE
|
DOPAMINE
|
25X5ML
|
B
|
35.47
|
1.42
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
0801P
|
DOPAMINE 40MG/ML INJ (SLS) (B)
|
DOPAMINE
|
DOPAMINE
|
25X5ML
|
B
|
40.37
|
1.6147
|
VIAL
|
0
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
40
|
0801U
|
DOPAMINE 40MG/ML INJ (MON/PHA)
|
DOPAMINE
|
DOPAMINE
|
5X5ML
|
B
|
8.02
|
1.60
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
0801V
|
DOPAMINE 40MG/ML INJ (STP) (B)
|
DOPAMINE
|
DOPAMINE
|
10X5ML
|
B
|
73.39
|
7.3395
|
AMP
|
0
|
BOX
|
STP
|
STEROP LABORATORIES
|
COL
|
COLLINS LTD
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
41
|
0813B
|
EPHEDRINE HCL 50MG/ML INJ (AKI)
|
EPHEDRINE HCL
|
EPHEDRINE HCL
|
10X1ML
|
B
|
2248.76
|
224.8761
|
VIAL
|
30
|
BOX
|
AKI
|
AKORN INC.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ALPHA & BETA ADRENERGIC AGONIST
|
|
|
|
|
40
|
0813C
|
EPHEDRINE HCL 50MG/ML INJ (VEV/AHI)
|
EPHEDRINE HYDROCHLORIDE
|
EPHEDRINE HCL
|
10X1ML
|
B
|
268.43
|
26.84
|
INJECTION
|
0
|
VIAL
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|
|
|
|
40
|
08234
|
ISOLIN 2MG/ML INJ (SLS/AHI) ISOPRENALINE
|
ISOPRENALINE
|
ISOLIN
|
5X1ML
|
BQ
|
37.92
|
7.58
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
08234
|
ISOLIN 2MG/ML INJ (SLS) ISOPRENALINE (BQ)
|
ISOPRENALINE
|
ISOLIN
|
5X1ML
|
BQ
|
37.92
|
7.5841
|
VIAL
|
1
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
40
|
0861E
|
NORADRENALINE 1MG/ML INJ (KWA/ATB)
|
NORADRENALINE
|
NORADRENALINE
|
10X4ML
|
BQ
|
27.05
|
2.71
|
INJECTION
|
0
|
AMP
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
